INS and diabetes mellitus: Human insulin knock-in mice, both homozygous and heterozygous, had a significantly reduced incidence of diabetes (p<0.0001, Log-rank test) compared to wildtype NOD mice when cohorts were followed for 300 days (Fig 4A).